Introduction
Pain is a major concern for individuals with cancer. The majority of cancer patients are older adults, a population that presents unique challenges for effective pain assessment and management, including misconceptions about pain, evaluating pain in those with cognitive impairments, increased sensitivity to medication side effects, multiple comorbidities, polypharmacy issues, practical barriers to adherence, and reluctance to take opioid analgesics [1] [2] [3] [4] [5] .
In the hospice setting, the majority of patients are older adults, many with advanced cancer. One of the priorities of hospice is to assure safe and comfortable dying, and although pain outcomes are better in hospice than nonhospice settings, there remains considerable variation. Patients in hospice still die with poorly controlled pain [6] . Evidence-based practice (EBP) is the use of current best research evidence in combination with clinical expertise and patient values in health care decision making [7] . However, the application of EBP for pain assessment and management by nurses and physicians is sporadic at best [8] [9] [10] [11] . Despite the availability of evidence-based (EB) practice guidelines to improve management of pain in older adults, adoption and use of recommendations based on best scientific evidence lags. This gap in recommended pain practices has been documented in the care of older adults with cancer pain in community-based hospice settings [12] .
Implementation strategies to promote the use of best practices by clinicians have been studied, but which combination of strategies are effective is not known. Translating Research into Practice (TRIP) research evaluates approaches to facilitate quality health care practices. This article reports on the results of a TRIP intervention, which is multifaceted and includes strategies designed to promote adoption of EB pain management practices for older adults with cancer in community-based hospice settings, hereafter referred to as TRIP-CA. Although a TRIP intervention was successful in improving pain management practices and in decreasing costs for older adults in an acute care setting, the effectiveness of a multifaceted TRIP model to promote the use of EB pain practices in the communitybased hospice setting is unknown [13, 14] . Following implementation of the TRIP-CA intervention, we hypothesized that [1] nurses and physicians at the experimental (E) hospices would show a greater increase in the adoption of EBP for pain management than those in the control (C) hospices; and [2] mean pain severity ratings for older patients with cancer admitted to E hospices would be lower at two time periods following hospice admission (P 2 = 3-7 days and P 3 = 8-14 days) than in the C group. In addition to data collected to address these hypotheses, post hoc focus groups and data from a process evaluation questionnaire completed by hospice staff were used to further evaluate the TRIP-CA intervention.
Methods

Study Design and Sample
A cluster randomized controlled trial (RCT) was used to test the effect of the multifaceted TRIP-CA intervention on promoting adoption of EBP for pain management in older adults with cancer receiving community-based hospice care. Sixteen Midwestern hospices were recruited with a representative sample of four small (average daily census [ADC] = 25 or less), eight medium (ADC = 26-100), and four large organizations (ADC = greater than 100). The majority (75%) reported an organizational structure with the hospice as part of a larger organization such as, a hospital, Department of Health, or health care organization. The remaining hospices were independent organizations. Fifteen of the 16 hospices were not-for-profit organizations. Inclusion criteria for the hospices were a minimum of 30 older patients admitted per year and serving older patients with a cancer diagnosis in a community-based hospice setting. For the purposes of this study, community-based hospice was defined as a setting where patients received hospice care in an environment that allowed the patient or their family caregiver to oversee the implementation of the pain treatment plan (e.g., personal home or assisted living). Hospices were first stratified by size and then randomly assigned into the E or C group.
Demographic data about staff were collected from the 16 participating hospices at two time points: baseline (August/ September 2006) and post-intervention (September/ October 2008). At baseline, the provider sample consisted of 383 nurses and 16 physicians. At post-intervention, the total number of nurses increased to 415, while the total number of physicians was unchanged. Demographic characteristics of providers are presented in Table 1 .
EBPs for pain assessment and management implemented by hospice medical professionals (nurses and physicians) were the target of the intervention. A sample of medical records (MRs) of older hospice patients cared for provided the data source to evaluate provider practices. Inclusion criteria for MR were patients 65 years or older, with a cancer diagnosis, newly admitted to hospice, and receiving hospice services in a community-based setting. An average of 30 MRs for patients meeting eligibility criteria were randomly selected from each hospice for the designated timeframes (baseline: from February 1 to July 30, 2006; post-intervention: from April 1 to September 30, 2008) . For hospices that did not have a minimum of 30 eligible MR during the defined period, all eligible records were selected.
Post hoc qualitative focus groups with hospice professionals (nurses, physicians, and social workers) were conducted after the intervention phase at each of the eight E sites to provide feedback on the TRIP-CA intervention and barriers and facilitators to practice change. The focus group participants completed a process evaluation questionnaire described below at the end of the intervention phase and prior to the focus group session. Detailed information on the focus group process and analysis is available elsewhere [15] .
The study was approved by the Institutional Human Subjects Review Board (IRB) at the University of Iowa, as well as corresponding human subjects review boards at the participating hospices with access to an internal IRB. The University of Iowa IRB served as the IRB of record for those hospices without an IRB.
TRIP-CA Intervention
TRIP-CA was adapted from a model developed by Rogers' diffusion of innovation (DoI) framework [13, 16, 17] . Figure 1 outlines the components of the multifaceted intervention. The TRIP-CA intervention follows the DoI framework that suggests that the components of the model (the characteristics of the innovation, the communication process, the social system, and the users) interact and impact the adoption of the innovation (e.g., cancer pain EBPs in older adults) and, ultimately, patient outcomes.
Characteristics of the EBP include the nature and complexity of the practice guidelines and the tools and resources to prompt and facilitate practice change. Opinion leaders, change champions, and educational training and outreach are key elements in the communication process that promote the use of EBP [17] [18] [19] [20] [21] . The social system, defined as a set of interrelated members engaged in joint problem solving to accomplish a common goal, can have a significant influence on adoption of EBPs [17, [22] [23] [24] [25] [26] and includes senior leadership support, training new staff, and modifying policies and procedures. User engagement through performance gap assessment, audit and feedback of practices, and adapting EBPs to the setting are influential as well [27, 28] .
The TRIP-CA intervention consisted of the engagement phase, a 5-month period (February to June 2007) preintervention, and the implementation phase, 12-month period (July 2007 to June 2008). During the engagement phase, all 16 hospices received copies of the three relevant clinical practice guidelines (CPG) existing at the time of the study that addressed the innovation for the TRIP-CA study, EBPs for cancer pain management in older adults in community-based hospices. The CPGs provided recommendations for acute pain management for older adults, pain management for adults with cancer, and pain management recommendations for patients in hospice and palliative care settings. These included The EBP Guideline: Acute Pain Management in Older Adults [29] ; The American Pain Society Guideline for the Management of Cancer Pain in Adults and Children [30] ; and The National Consensus Project (NCP) Clinical Practice Guideline for Quality Palliative Care [31] .
In addition, the eight E hospices participated in a number of activities during the engagement phase including: 1) selection of local opinion leaders (called pain facilitators [PF] ), nurse champions (NC), and physician champions (PC); 2) participation by PF and champions in a 3-day train-the-trainer (TTT) program hosted by the grant team, which provided an overview of project implementation and EBPs for pain assessment and management for older adults with cancer in a hospice setting; 3) review of performance gap assessment data, which included an on-site review of their hospice specific baseline data on 48 indicators of EBPs identified from the guidelines; 4) targeted senior leadership engagement, which consisted of an on-site meeting with the hospice leadership team at each E site to detail the project, review data, and encourage participation in and support of the intervention; and 5) on-site academic detailing about pain EBPs with the PCs provided by a physician with expertise in both pain management and the hospice setting.
At the beginning of the implementation phase, the eight E hospices received EBP pain resources and aid to facilitate use of EBP recommendations, including pocket-sized laminated pain rating scales for all nurses, copies of quick reference guides, and patient education handouts related to non-pharmacologic interventions. During the first 3 months of the implementation phase, all nurses at the E sites completed an EBP pain assessment and management education program provided via DVD. On a monthly basis during the implementation phase, the E sites also received an outreach visit from the grant expert nurse, who provided support and counseling related to EBP pain issues, as well as issues related to implementation of the intervention. The expert nurse also completed a chart audit on the 48 EBP indicators during her monthly visit, which provided data for bi-monthly audit and feedback to the sites comparing with baseline practices identified in the engagement phase. The expert nurse was also available during monthly site visits and via email to assist the E hospices as they modified their standards and documentation forms to ensure that they aligned with EBPs for pain assessment and management.
Additional activities during the implementation phase included a monthly teleconference among the local PF, NC, and grant investigators and staff to discuss the intervention and implementation progress and strategies to assist in promoting uptake. This activity also supported networking and sharing successes between the E sites. The final activity during the implementation phase was an e-mail LISTSERV (L-Soft International Inc.; Landover, MD, USA) facilitated by experts in pain management and hospice from medicine, nursing, social work, and pharmacy. Any interested staff from the E hospices could participate in the weekly discussions related to pain assessment and management, as well as receive feedback related to specific pain-related issues that they were dealing with in their practice.
Study Instruments and Measures
The dependent variables for this study were the adoption of 11 EB cancer pain practices for older adults in a community-based hospice setting and mean pain severity (intensity) of older adults with cancer served by the hospices. The medical record abstraction tool was developed specifically for grant use based on the comprehensive list of 48 indicators of EBP for pain management audited during the intervention and was used to provide data for calculating the measure of overall adoption of EB cancer pain practice indicator for older adults and mean pain severity. Due to the nature of the hospice MR (e.g., variable formats, narrative in nature, and lack of consistent language), data were abstracted by two trained research assistants (RA), who were nurses with clinical experience working with older adults in hospice, oncology, or long-term care settings. Any discrepancies were reviewed by a third RA to adjudicate entry. The adoption of EB cancer pain practices was measured by a composite of key provider practices on the cancer pain practice index (CPPI) developed by the research team using a modified Delphi approach with national pain and hospice experts. The CPPI focuses on 11 key EBP indicators for pain relevant to older adults with cancer receiving communitybased hospice care and included pharmacological and non-pharmacological management ( Table 3 provides the complete list of the 11 EBPs included on the CPPI).
To determine a total score on the CPPI, the number of points received on the applicable items for that particular patient (maximum of 11, if all items apply) is divided by the maximum score possible on all applicable items resulting in the percentage of EBPs the patient received. The higher the CPPI score, the greater the percentage of EBPs the patient received. Although ideally all patients would receive each applicable pain practice 100% of the time, with input from an expert panel, a target of 75% as acceptable for success on each indicator was established. Inter-rater reliability of the CPPI was established at 93% with intra-rater reliability of 95%. A detailed description of the CPPI development and psychometrics is reported elsewhere [32] .
All hospice executive directors or their delegates completed an organizational demographic questionnaire at baseline and post-intervention related to 1) organizational characteristics; 2) staff characteristics; and 3) pain policies, procedures, and available pain resources.
Mean pain severity was based on 0-10 numeric rating scale (NRS) reports of pain severity recorded in the medical record. Patients' pain severity levels on a 0-to 10-point scale were defined as none (0), mild (1-4), moderate (5-6), and severe (7-10) [33, 34] . Patients who reported pain at "0" on admission, but who had orders for pharmacologic or non-pharmacologic therapies, were included in the group with pain. For patients with only a verbal descriptor scale (VDS) report of pain, the VDS scores were converted into numeric scores by calculating the mean pain severities for each category (mild, moderate, and severe) based on all patient numeric pain severity scores in the sample. Patients with cognitive impairments who were not able to self-report pain were not included in the analysis of pain severity (N = 35), as no objective measure of pain was in the MR for most patients.
A post hoc process evaluation questionnaire developed specifically for the grant was used to gather information about the TRIP-CA intervention from E hospice staff. The questionnaire used a five-point Likert scale (1 = not helpful and 5 = very helpful) to rate all intervention activities and resources.
Post-intervention focus groups, conducted by a trained nurse facilitator, were guided by the qualitative interview guide, a semi-structured interview tool to solicit feedback from E hospice staff on perceptions of the impact of the intervention components on the implementation process in their facility, and barriers and facilitators to EBP implementation.
Data Analysis
Study aims were analyzed using descriptive statistics and linear and logistic regression models. All analyses were performed using SAS 9.2 (SAS Institute Inc.; Cary, North Carolina, USA). A P value of 0.05 was required for statistical significance.
Demographic characteristics of patients, nurses/ physicians, and hospices were analyzed using descriptive statistics. Differences in demographic characteristics between the E and the C groups were assessed using binomial logistic regression (for variables with two categories) or multinomial logistic regression (for variables with more than two categories). In modeling the demographic characteristics of the hospices, the hospice was treated as the unit of analysis. When appropriate, the models were adjusted for overdispersion.
The pain severity of each patient was computed based on the mean pain severity of all assessments in each of three periods in their hospice stay: P 1 = admission, defined as the first 48 hours; P 2 = days 3-7; and P 3 = days 8-14. P values were obtained from a proportional odds model to test if the change of the number of patients from baseline to post-intervention across three categories of pain severity (mild, moderate, and severe) was significantly different between the E and the C group.
The key and additional pain practice indicators were recorded as a 0/1 binary variable (reflecting whether the patient received the practice). For indicators based on multiple components, achievement on at least 75% of the components was required to receive a 1. For indicators that had only one component but were completed multiple times over the 2-week period, 100% achievement was required to receive a 1. For each patient, the CPPI was calculated as the percent of key pain practice indicators received of those that were applicable to that patient. The overall CPPI score was summarized by the mean percentage across patients. In modeling the CPPI, the overall measure of EBP adoption, the patient was treated as the unit of analysis. To account for the correlation between patients within the same hospice, we used generalized estimating equations (GEE) and assumed an exchangeable working correlation structure [35] .
The main explanatory variable reflecting the intervention indicates whether the patient's medical record was part of the baseline data or post-intervention data, and in the E or C group. Nine additional explanatory variables were considered: patient variables age and gender; hospice variables size and organizational structure; nurse variables registered nurse (RN) education, RN certification, and RN case load; and physician variables medical director status and medical director certification. The variable race was not used due to an insufficient representation of patients in some of the categories.
To determine the final model, forward selection was performed on the initial model featuring the intervention variable only. Significant explanatory variables, along with two-way interactions between these variables and the intervention variable, were included in the final model.
The effect of the TRIP-CA intervention can be summarized by the difference between improvements on the mean CPPI from baseline to post-intervention in the E group compared with the C group. Our goal was to characterize the intervention effect after controlling for explanatory variables and accounting for baseline differences. We applied Poisson generalized linear models (GLMs) with the CPPI as the dependent variable.
Analyses of other outcomes were also conducted using the GLM/GEE framework. The normal distribution was assumed for continuous outcomes, the binomial or multinomial distribution was assumed for categorical outcomes, and the Poisson distribution was assumed for count outcomes.
Results
Characteristics of Providers
Demographic characteristics of providers were comparable for the E and C groups with no significant differences at baseline and post-intervention. Differences between E sites, baseline to post-intervention, and C sites, baseline to post-intervention, were also not significant. Details on provider demographics are available in Table 1 .
Patient Characteristics
The total patient sample from baseline (T . Mean age at T 1 was 77.6 years (E = 77.0; C = 78.3) and at T 2 was 78.0 years (E = 78.3; C = 77.7). The sample was generally cognitively intact at admission, with only 15.3% of the sample reported as having a cognitive impairment (N = 113). For the patients listed as cognitively impaired (CI) at admission, 66.3% were able to self-report pain using a NRS or VDS. Of the remaining 35 patients with CI and no self-report documented, 14 (40%) had pain behaviors documented in the admission assessment, but not in a consistent manner using a validated pain behavior tool. The remaining 21 (60%) patients had no pain assessment documented at admission. Demo-graphic characteristics of the patients in the E and C groups were similar for both time periods with no significant differences noted (Table 2) .
Pain Severity
Overall, 40% (N = 295) of patients had a report of pain greater than 0 at hospice admission. Additionally, 43% (N = 314) had an order for a scheduled non-opioid or opioid analgesic and reported pain, so we inferred that they had pain that was controlled.
Of the 738 patients in the sample, 59.5% had at least one report of pain greater than zero during the first 14 days of hospice care. Of the remaining patients, 16.1% had no pain across all assessments. The final 4.2% of patients had missing data or no pain assessments documented during the first 14 days of hospice care. The initial pain severity score (first pain assessment documented) for patients with at least one pain score documented (N = 439) ranged from none to severe, with 35.1% of patients reporting no pain and 35.8% reporting mild pain. However, the admission pain severity score for 128 patients was at the moderate level or greater, with 15% of patients reporting moderate pain and 14.1% reporting severe pain. The last pain severity score for patients with two or more pain scores in the first 14 days of hospice care again ranged from no pain to severe pain. Of the 410 patients in this group, 49.8% reported no pain on their last report of pain, 26.3% reported mild pain; 13.7% reported moderate pain, and 10.2% reported severe pain as their final pain severity rating documented during the first 2 weeks of hospice care.
Across all hospice sites, pain assessment was documented an average of 4.2 times per patient during the first 2 weeks of hospice care with no significant difference noted between E and C sites. The frequency of pain severity documentation ranged from 0 (4.2%) to 5 times or more (41.3%). Of the 707 patients with at least one pain score reported at some point during the 2-week period, 19.6% reported severe pain at least once. Table 3 provides a comparison of individual EB pain practice indicators and the overall CPPI outcome measure between E and C groups at baseline and postintervention. Consistent across both E and C groups at baseline and post-intervention, only 30-34% of key applicable EB pain practices were received. There were few EB Remark: P values were calculated based on the logistic regression model (binomial/polynomial outcome) with contrast tests. N/A = not available. * P values were calculated using the Fisher's exact test due to some small numbers in the contingency. † P value was not available due to zero count in one cell from the contrast test.
Provider Pain Practices
pain practices that more than 75% of patients for which the practice was applicable received. Practices that were more consistently evident were using a valid pain scale to assess pain, completing a primary pain assessment of pain characteristics, and administering appropriate analgesics for level of pain report. Practices that were particularly low were completing a comprehensive pain assessment, reassessing pain within 24 hours in those with moderate/severe pain, and monitoring for most common analgesic-induced side effects.
Impact of Organizational and Provider Characteristics on Provider Practices Overall
The Poisson GEE analysis examined the impact of organizational and provider characteristics on the overall CPPI score for all hospices (Table 4) . Across hospices, five variables were significantly related to CPPI score: patient age, hospice size, nurse education level, nurse certification, and nurse case load. Patients between 65 and 74 years of age had an overall mean CPPI 10% higher than patients over 85 years of age. Patients from small hospices (ADC < 25) had an overall mean CPPI score 11% higher than patients from large hospices (ADC > 100). Patients from medium hospices (ADC 26-100) had an overall mean CPPI score 23% lower than patients from large hospices (ADC > 100). Patients from hospices with 40% or more of their nurses having at least a BSN had mean CPPI scores 6% higher than those patients from hospices with fewer nurses with BSN or higher. Patients from hospices with 20% or more of their nurses with certification in hospice/palliative care or pain management had CPPI scores 6% higher than those from hospices with fewer nurses certified. Finally, patients from hospices with nurse caseloads greater than 10 had CPPI scores 29% higher than patients from hospices with lower nurse case loads.
The following variables showed no significant relationship to the CPPI: patient gender, patient race, organizational structure (independent agency vs part of a larger organization), medical director's employment status (volunteer, part time paid, or full time paid), and medical director certification (certification in hospice and palliative care, pain management, and other). Significant variables were included in the final GEE modeling to address the research questions (Table 4) . Hypothesis 1. We hypothesized that following the implementation of the TRIP-CA intervention, nurses and physicians at the E hospice sites would show a greater increase in the adoption of EPB for pain than those in the C group.
The contrast tests in the final modeling (Table 4) suggest that while both the E and the C groups showed improvement from baseline to post-intervention on the CPPI, there was no significant difference in change on the CPPI between E and C groups in our primary modeling when controlling for explanatory variables (P = 0.06). Mediumsized E hospices did show a greater improvement in CPPI mean score than medium-sized C sites. However, both small and large C hospices had a greater improvement on the CPPI score than their E counterparts. Both the E and the C groups had high and low performing hospices, based on the change in the mean CPPI score from baseline to post-intervention. In the E group, 50% of the eight sites showed improvement on the mean CPPI from baseline to post-intervention. In the C group, 62% of the eight sites showed improvement on the mean CPPI from baseline to post-intervention. Table 3 provides information about the overall CPPI outcomes and individual CPPI indicators for E compared with C groups.
Hypothesis 2. We hypothesized that following the implementation of the TRIP-CA intervention, mean pain severity ratings for older patients with cancer admitted to E hospices would be lower at two time periods following hospice admission (P 2 = 3-7 days and P 3 = 8-14 days) compared with the C group.
Change in pain severity means from baseline to postintervention in the E and C groups for patients with at least one pain score documented show consistent greater decreases in the E group at P 1 (1st 48 hours) (1.95-1.80), P 2 (1.61-1.38), and P 3 (1.62-1.43) compared with the C group in which pain severity increased at P 1 (1.54-1.69) and P 3 (1.24-1.58), and decreased at P 2 (1.64-1.42). A linear regression GEE analysis, controlling for hospicespecific cluster effects, showed decreases in pain severity from baseline to post-intervention during the second week of hospice and in the last pain severity rating in those with two or more pain scores: however, the results were not statistically significant (see Table 5 ).
There was a relatively small percentage of patients experiencing moderate to severe pain at baseline making it difficult to detect a difference post-intervention. The changes in pain severity were small and not likely to be clinically significant. * Ratio of the mean CPPI for a particular group relative to the mean CPPI for the reference group. † The Intervention variable is based on four categories: experimental baseline (EB)-baseline data for the experimental group, experimental post-intervention (EPI)-post-intervention data for the experimental group, control baseline (CB)-baseline data for the control group, and control post-intervention (CPI)-post-intervention data for the control group. ‡ Interactions test whether the effect of a variable on the mean CPPI depends on the category of the intervention variable. § The contrast (EPI-EB) tests the improvement of the mean CPPI from baseline to post-intervention in the experimental group. ¶ The contrast (CPI-CB) tests the improvement of the mean CPPI from baseline to post-intervention in the control group. ** The contrast (EPI-EB)-(CPI-CB) compares the improvements on the mean CPPI from baseline to post-intervention in the experimental group and in the control group.
Post-Intervention Data about the TRIP-CA Intervention
Of the activities and resources listed on the process evaluation questionnaire as part of the TRIP-CA intervention, 16 received a mean score of 4.5 or greater (5 = very helpful). The top five activities/resources identified by E staff as being most helpful in implementing EBP for cancer pain in older adults included: 1) implementing standard pain assessment tools, 2) involvement of a local PF, 3) the TTT program, 4) laminated pain tools, and 5) audit and feedback. Conversely, the five activities/resources identified as the least helpful to EBP implementation (scoring less than 3.75) were 1) involvement of PC; 2) implementing motivational initiatives; 3) marketing/staff incentive-pocket calculator; 4) press releases to use for hospice newsletters, local papers, etc.; and 5) key elements handout for physicians. Post-intervention focus groups provided feedback useful in interpreting study findings with details provided elsewhere [15] .
Discussion
Although the TRIP-CA intervention resulted in significant improvements on selected practice indicators for the E group, there was not a significant intervention effect on the overall provider adoption score, the CPPI. The variations between hospices suggest there may be location-specific factors important to the implementation and dissemination of EBPs and their adoption that were not controllable through the explanatory variables identified. The process of adopting a complex practice change with numerous recommendations is challenging [8] [9] [10] . The difficulties in changing established health care practices have been well documented in the acute care setting [13, [36] [37] [38] [39] [40] [41] . However, less literature is available on implementing EBP in community-based settings, including hospice [8, 42, 43] . The findings that fewer than 35% of applicable EBPs are received, and that 24% of patients reported moderate to severe pain as their last documented pain score, reinforce the need for continued efforts to address pain challenges in this setting caring for older adults with cancer pain.
In evaluating the effect of the TRIP-CA intervention, a number of factors must be considered: the unique characteristics and culture of the hospice setting, the complexity of the EBP topic that is being promoted, and the competing priorities of the practice sites. The decentralized environment of hospice made it challenging to communicate all components of the TRIP-CA intervention directly to the staff (RNs and physicians) implementing the EBPs for pain. EBP information and suggestions for implementation strategies were often provided to the hospice PF and NC with limited influence over how this information was shared with other staff. Consequently, there were considerable variances across hospice settings with other information and resource sharing, such as expert outreach advice, additional training, and communication of audit and feedback data with frontline staff. A knowledge gap related to the overall understanding of EBP by staff in the hospice settings was also identified in the postintervention focus groups. Future efforts should include education of local staff on what EBP is, the benefits of EBP, and its contribution to improved patient care.
Barriers identified during the post-intervention focus groups may have had a considerable impact on the implementation process. Some of the confounding factors identified were not anticipated (e.g., natural disasters impacting a number of the sites and repeated turnover of local project leaders). However, developing a plan that includes strategies for dealing with potential barriers to implementation may serve as a road map for future studies. A detailed description of barriers and facilitators identified in the TRIP-CA study is reported elsewhere [15] .
Another factor that must be considered when reviewing the impact of the TRIP-CA intervention is the complexity of the innovation (e.g., practice change). Collectively, the EB guidelines serving as the foundation for EBP recommendations resulted in 48 indicators of best practice. As part of tailoring to one's organization, we did not prescribe what core practices were to be addressed, but rather encouraged each hospice to examine their baseline data and to establish its own priorities for change. While the audit and feedback activity presented site-specific feedback on the 48 indicators of best practice and was rated as being very helpful, the number and scope of practice recommendations may have impacted the priority areas chosen by the hospices and the practice changes observed. The 11-item overall adherence outcome measure (CPPI) was developed simultaneously with the intervention implementation and may have been a better approach for sharing on-going audit and feedback data in a more focused, concise format [32] . Other recent implementation research supports better outcomes with simple practice changes, and the length of time for implementation of complex practices takes longer than for simple practices [17, 29, 44] . For complex innovations, a staging of practice changes may provide better outcomes.
While the E site staff indicated that having a PF at each site was instrumental to the implementation process, the format for selecting these project leaders should be considered. In the current study, each E site was allowed to "select/appoint" a nurse PF and the NC/PC for their hospice based on a set of criteria/characteristics that included important qualities needed in these roles [45, 46] . In the hospice setting, there were often few nurses or physicians from which to select for these important roles.
It is unknown if individuals chosen were viewed as "leaders" by their peers or if enough time to complete the additional duties of the position was provided. Future research should address these potential limitations.
A challenge for implementation science research is identifying methods for measuring fidelity to the implementation intervention [47] [48] [49] . Our study did not prospectively measure the fidelity to each of the TRIP-CA intervention components, although the variability in hospice outcomes from the TRIP-CA intervention suggests that this may provide valuable information about the strategies used to promote change. Anecdotally, we observed considerable variance among hospices regarding their use of key activities and resources provided as part of the intervention. For example, all E site PF and change champions received their organization's performance gap assessment data prior to the implementation phase of the study and audit and feedback data every 2 months during the intervention phase. However, the dissemination of this information to end users varied. Another area of variance in this study was seen in the level of participation in the TTT program offered to the E sites during the study engagement phase. Each E site was encouraged to send three representatives, specifically its PF, NC, and PC, to the 3-day TTT program provided by the research team and other expert consultants. All eight E sites sent at least one representative, with only two sites sending their complete local leadership team. While participants rated this activity as helpful, it remains unclear what mechanisms were used to share the information gained at the TTT program at each local site.
Another intervention component with significant variation was the interaction with the expert nurse during outreach consultation. While all E sites received 10 site visits, the interaction with hospice staff during those visits differed based on the requests of the sites. Some E hospices requested the expert nurse interact with all their nurses during staff meetings or training sessions, while others preferred to have only the PF or NC meet with the expert nurse. Thus, the level of engagement of the outreach nurse with hospice staff was variable across the E sites. Additionally, engagement of physicians in the implementation process was difficult as noted by the ratings of nurses and other non-physician hospice staff on the process evaluation questionnaire. Items related to physician involvement were all rated as least helpful in implementing the intervention and were also mentioned in the post-intervention focus groups as barriers to implementation [15] . The issue of engaging physicians was also noted in the prior TRIP study conducted in the acute care setting [13] .
Understanding implementation intervention fidelity, the degree to which an intervention is delivered as designed, is important in evaluating the effectiveness of an intervention [50, 51] . A key challenge with implementation research is how to promote adoption of EBPs with tailoring to the individual organization, while taking into account the variability of how implementation components are enacted at each E site. This does, however, reflect real-world practices and needs to be considered in effectiveness studies.
To our knowledge, this is the first clustered RCT to test the effectiveness of an implementation intervention for promoting adoption of EB pain management practices in hospice settings. While success of the TRIP-CA intervention in overall provider adoption of best practices was not demonstrated, the intervention did impact patient pain severity ratings and selected pain practices, and qualitative feedback provided insights into the usefulness of the various TRIP-CA intervention components. The study contributed to knowledge regarding issues that hospices should consider when implementing a specific practice change and provided valuable data on what components of the TRIP-CA intervention were considered helpful by users in implementing EBP for pain management in the hospice setting.
Limitations
The sensitivity of the CPPI to detect change in provider practices was not established a priori, although individual practice indicators provided similar outcome findings as the summative score on the CPPI. Further study of the best approaches to measure provider practices is warranted. The focus of this study was pain in older adults with cancer in community-based hospice settings and thus, cannot be generalized to other community-based settings.
The use of MR data as the source to determine pain assessment and management practices is a potential limitation of the data collection. However, a number of studies have used this method effectively [3, 13, 52] . Other approaches, including direct observation, videotaped observation, and audio-taped sessions, were considered, but each has limitations and is not feasible in a large implementation study [50] . Due to cost, potential for bias in direct observation, and the role of MRs as the regulatory and legal foundation for provision of care, we determined that MR abstraction was the best option for this study. Assuring quality and accurate documentation of provider practices is an issue that needs attention for research in hospices and for clinical practice.
Inability to measure or assure consistent engagement with each of the intervention components impacts understanding of the intervention effect on outcomes. Because implementation interventions involve multiple users and multiple strategies in real-world settings, this gap in knowledge is of particular importance for future study.
Conclusions and Recommendations for Future Research
The TRIP-CA intervention was not successful in significantly changing provider practices across a group of selected key pain practices for management of cancer pain in older adults in community hospices. Considering that patients received less than 35% of the recommended EBPs that were applicable to their circumstances, there is need for continued efforts to address pain practice in this setting of care.
It is clear from this study that differences in practice settings can have a considerable impact on the outcome of an implementation intervention. The hospice setting offers contextual and operational factors unique from acute care that impact approaches to translating EBPs into consistent use. Future research should focus on determining what factors specific to community-based hospice should be targeted when implementing an EBP intervention. It is equally important to consider concurrently measuring fidelity to the implementation intervention and examining factors impacting fidelity in the interpretation of study outcomes.
The conduct of multicomponent practice change interventions is research intensive and may not be a model that is replicable on a broad scale in community-based settings, such as hospice. Future research should explore intervention approaches that rely less on research team members and can be more fully implemented by organizational staff. Consideration of use of technology to address identified barriers could have benefit.
